HSV-1 reactivation as measured by the presence of baseline anti-HSV-1 IgM antibodies is associated with increased risk of developing AD (Letenneur et al., 2008; Lövheim et al., 2015a). This evidence concerns the gene CD40LG and Alzheimer disease.